Literature DB >> 23106422

H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.

Gwendolyn A Bailey1, Eric W Price, Brian M Zeglis, Cara L Ferreira, Eszter Boros, Michael J Lacasse, Brian O Patrick, Jason S Lewis, Michael J Adam, Chris Orvig.   

Abstract

Preliminary experiments with the novel acyclic triazole-containing bifunctional chelator H2azapa and the radiometals (64)Cu, (67)Ga, (111)In, and (177)Lu have established its significant versatile potential as an alternative to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) for metal-based radiopharmaceuticals. Unlike DOTA, H2azapa radiolabels quantitatively with (64)Cu, (67)Ga, (111)In, and (177)Lu in 10 min at room temperature. In vitro competition experiments with human blood serum show that (64)Cu remained predominantly chelate-bound, with only 2% transchelated to serum proteins after 20 h. Biodistribution experiments with [(64)Cu(azapa)] in mice reveal uptake in various organs, particularly in the liver, lungs, heart, intestines, and kidneys. When compared to [(64)Cu(DOTA)](2-), the lipophilic neutral [(64)Cu(azapa)] was cleared through the gastrointestinal tract and accumulated in the liver, which is common for lipophilic compounds or free (64)Cu. The chelator H2azapa is a model complex for a click-based bifunctional chelating agent, and the lipophilic benzyl "place-holders" will be replaced by hydrophilic peptides to modulate the pharmacokinetics and direct activity away from the liver and gut. The solid-state molecular structure of [In(azapa)(H2O)][ClO4] reveals a very rare eight-coordinate distorted square antiprismatic geometry with one triazole arm bound, and the structure of [(64)Cu(azapa)] shows a distorted octahedral geometry. The present study demonstrates significant potential for bioconjugates of H2azapa as alternatives to DOTA in copper-based radiopharmaceuticals, with the highly modular and "clickable" molecular scaffold of H2azapa easily modified into a variety of bioconjugates. H2azapa is a versatile addition to the "pa" family, joining the previously published H2dedpa ((67/68)Ga and (64)Cu), H4octapa ((111)In, (177)Lu, and (90)Y), and H5decapa ((225)Ac) to cover a wide range of important nuclides.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23106422      PMCID: PMC4968691          DOI: 10.1021/ic302225z

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  60 in total

1.  "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step.

Authors:  Thomas L Mindt; Harriet Struthers; Luc Brans; Todor Anguelov; Christian Schweinsberg; Veronique Maes; Dirk Tourwé; Roger Schibli
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

2.  Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.

Authors:  G R Mirick; R T O'Donnell; S J DeNardo; S Shen; C F Meares; G L DeNardo
Journal:  Nucl Med Biol       Date:  1999-10       Impact factor: 2.408

3.  Relation between the location of elements in the periodic table and various organ-uptake rates.

Authors:  A Ando; I Ando; T Hiraki; K Hisada
Journal:  Int J Rad Appl Instrum B       Date:  1989

4.  Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy.

Authors:  Kim Nguyen; Jesse J Parry; Buck E Rogers; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2011-11-04       Impact factor: 2.408

5.  Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.

Authors:  Richard Laforest; Farrokh Dehdashti; Jason S Lewis; Sally W Schwarz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-23       Impact factor: 9.236

6.  1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.

Authors:  Ioannis Bratsos; Damijana Urankar; Ennio Zangrando; Petia Genova-Kalou; Janez Košmrlj; Enzo Alessio; Iztok Turel
Journal:  Dalton Trans       Date:  2011-04-05       Impact factor: 4.390

Review 7.  Copper chelation chemistry and its role in copper radiopharmaceuticals.

Authors:  T J Wadas; E H Wong; G R Weisman; C J Anderson
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

8.  H4octapa: an acyclic chelator for 111In radiopharmaceuticals.

Authors:  Eric W Price; Jacqueline F Cawthray; Gwendolyn A Bailey; Cara L Ferreira; Eszter Boros; Michael J Adam; Chris Orvig
Journal:  J Am Chem Soc       Date:  2012-05-11       Impact factor: 15.419

9.  Zn(ii), Cd(ii) and Pb(ii) complexation with pyridinecarboxylate containing ligands.

Authors:  Raquel Ferreirós-Martínez; David Esteban-Gómez; Carlos Platas-Iglesias; Andrés de Blas; Teresa Rodríguez-Blas
Journal:  Dalton Trans       Date:  2008-09-09       Impact factor: 4.390

10.  High thermodynamic stability and extraordinary kinetic inertness of copper(II) complexes with 1,4,8,11-tetraazacyclotetradecane-1,8-bis(methylphosphonic acid): example of a rare isomerism between kinetically inert penta- and hexacoordinated copper(II) complexes.

Authors:  Jan Kotek; Premysl Lubal; Petr Hermann; Ivana Císarová; Ivan Lukes; Tomás Godula; Ivona Svobodová; Petr Táborský; Josef Havel
Journal:  Chemistry       Date:  2003-01-03       Impact factor: 5.236

View more
  13 in total

1.  Non-cross-bridged tetraazamacrocyclic chelator for stable (64)cu-based radiopharmaceuticals.

Authors:  Ajit V Dale; Darpan N Pandya; Jung Young Kim; Hochun Lee; Yeong Su Ha; Nikunj Bhatt; Jonghee Kim; Jeong Ju Seo; Woonghee Lee; Sung Hong Kim; Young-Ran Yoon; Gwang Il An; Jeongsoo Yoo
Journal:  ACS Med Chem Lett       Date:  2013-07-25       Impact factor: 4.345

2.  H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.

Authors:  Eric W Price; Brian M Zeglis; Jacqueline F Cawthray; Caterina F Ramogida; Nicholas Ramos; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  J Am Chem Soc       Date:  2013-08-15       Impact factor: 15.419

3.  New surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studies.

Authors:  Prakash D Nallathamby; Ninell P Mortensen; Heather A Palko; Mike Malfatti; Catherine Smith; James Sonnett; Mitchel J Doktycz; Baohua Gu; Ryan K Roeder; Wei Wang; Scott T Retterer
Journal:  Nanoscale       Date:  2015-04-21       Impact factor: 7.790

Review 4.  Click Chemistry and Radiochemistry: The First 10 Years.

Authors:  Jan-Philip Meyer; Pierre Adumeau; Jason S Lewis; Brian M Zeglis
Journal:  Bioconjug Chem       Date:  2016-11-22       Impact factor: 4.774

Review 5.  A review of advances in the last decade on targeted cancer therapy using 177Lu: focusing on 177Lu produced by the direct neutron activation route.

Authors:  Rubel Chakravarty; Sudipta Chakraborty
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

6.  Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.

Authors:  Eszter Boros; Elena Rybak-Akimova; Jason P Holland; Tyson Rietz; Nicholas Rotile; Francesco Blasi; Helen Day; Reza Latifi; Peter Caravan
Journal:  Mol Pharm       Date:  2013-12-11       Impact factor: 4.939

7.  H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.

Authors:  Eric W Price; Brian M Zeglis; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Dalton Trans       Date:  2014-01-07       Impact factor: 4.390

8.  Brightly Luminescent and Kinetically Inert Lanthanide Bioprobes Based on Linear and Preorganized Chelators.

Authors:  Ali Mohamadi; Lawrence W Miller
Journal:  Bioconjug Chem       Date:  2016-10-03       Impact factor: 4.774

9.  Oxyaapa: A Picolinate-Based Ligand with Five Oxygen Donors that Strongly Chelates Lanthanides.

Authors:  Aohan Hu; Ivan Keresztes; Samantha N MacMillan; Yang Yang; Erdong Ding; Warren R Zipfel; Robert A DiStasio; John W Babich; Justin J Wilson
Journal:  Inorg Chem       Date:  2020-03-27       Impact factor: 5.165

10.  What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.

Authors:  Eric W Price; Brian M Zeglis; Jacqueline F Cawthray; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Inorg Chem       Date:  2014-09-05       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.